Cytovance Biologics is a leader in the development and manufacturing of clinical and commercial large molecule APIs from mammalian cell culture, microbial fermentation, and plasmid DNA. They are able to support products throughout the journey from R&D to regulatory approval and commercial production. Their comprehensive service portfolio of strain and cell line development, process development, analytical capabilities, cell banking, scale-up, cGMP manufacturing, program management, and life cycle support allows them to add a wide array of new capabilities and develop a comprehensive suite of solutions capable of serving customers across the drug development spectrum. Based in Oklahoma City, Oklahoma, the company's facilities feature 21,000 square feet of lab space and 140,000 square feet of cGMP manufacturing space.